Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001091818-24-000034
Filing Date
2024-04-01
Accepted
2024-04-01 15:35:49
Documents
39
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 YEAR- END REPORT - DEC. 31, 2023 bfnh12302310k.htm   iXBRL 10-K 325351
2 CERTIFICATION ex31_1.htm EX-31.1 4809
3 CERTIFICATION ex31_2.htm EX-31.2 4920
4 CERTIFICATION ex32_1.htm EX-32.1 1943
5 CERTIFICATION ex32_2.htm EX-32.2 2032
11 image_001.jpg GRAPHIC 21193
12 image_002.jpg GRAPHIC 14139
13 image_003.jpg GRAPHIC 200486
  Complete submission text file 0001091818-24-000034.txt   2296557

Data Files

Seq Description Document Type Size
6 bfnh-20231231.xsd EX-101.SCH 11058
7 bfnh-20231231_cal.xml EX-101.CAL 18870
8 bfnh-20231231_def.xml EX-101.DEF 25660
9 bfnh-20231231_lab.xml EX-101.LAB 152244
10 bfnh-20231231_pre.xml EX-101.PRE 114499
42 EXTRACTED XBRL INSTANCE DOCUMENT bfnh12302310k_htm.xml XML 75466
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51074 | Film No.: 24808767
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)